Development of Novel <sup>111</sup>In/<sup>225</sup>Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics-Reference-Cited by-同舟云学术

Development of Novel ¹¹¹In/²²⁵Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics

Published:2023-06-07 Issue:12 Volume:66 Page:8043-8053
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tsuchihashi Shohei¹,Nakashima Kazuma¹,Tarumizu Yuta²,Ichikawa Hiroaki²,Jinda Hiroki¹,Watanabe Hiroyuki¹^ORCID,Ono Masahiro¹^ORCID

Affiliation:

1. Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan

2. Research Center, Nihon Medi-Physics Co., Ltd., 3-1 Sodegaura-shi, Chiba 299-0266, Japan

Funder

Nihon Medi-Physics

Japan Agency for Medical Research and Development

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00346

Reference40 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry

3. Cancer statistics, 2023

4. Expression of Prostate-Specific Membrane Antigen in Normal and Malignant Human Tissues

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-affinity-pharmacokinetics relationships of 111In-labeled PSMA-targeted ligands with different albumin binders;Nuclear Medicine and Biology;2024-11

2. Effect of Linker Entities on Pharmacokinetics of ¹¹¹In-Labeled Prostate-Specific Membrane Antigen-Targeting Ligands with an Albumin Binder;ACS Pharmacology & Translational Science;2024-07-09

3. Synthesis and Evaluation of a Cathepsin B–Recognizing Trifunctional Chelating Agent to Improve Tumor Retention of Radioimmunoconjugates;Journal of Labelled Compounds and Radiopharmaceuticals;2024-06-05

4. Synthesis and evaluation of novel trifunctional chelating agents for pretargeting approach using albumin binder to improve tumor accumulation;Nuclear Medicine and Biology;2024-05

5. Fundamental evaluation regarding the relationship between albumin-binding and tumor accumulation of PSMA-targeting radioligands;Annals of Nuclear Medicine;2024-04-27